169 related articles for article (PubMed ID: 6107935)
1. Evidence that a preferred substrate for type B monoamine oxidase mediates stimulus properties of MAO inhibitors: a possible role for beta-phenylethylamine in the cocaine cue.
Colpaert FC; Niemegeers CJ; Janssen PA
Pharmacol Biochem Behav; 1980 Oct; 13(4):513-7. PubMed ID: 6107935
[TBL] [Abstract][Full Text] [Related]
2. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
Lenzen S; Nahrstedt H; Panten U
Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):190-5. PubMed ID: 6419132
[TBL] [Abstract][Full Text] [Related]
3. Effects of monoamine oxidase inhibitors on cocaine discrimination in rats.
Gatch MB; Taylor CM; Flores E; Selvig M; Forster MJ
Behav Pharmacol; 2006 Mar; 17(2):151-9. PubMed ID: 16495723
[TBL] [Abstract][Full Text] [Related]
4. Metabolic transformation plays a primary role in the psychostimulant-like discriminative-stimulus effects of selegiline [(R)-(-)-deprenyl].
Yasar S; Justinova Z; Lee SH; Stefanski R; Goldberg SR; Tanda G
J Pharmacol Exp Ther; 2006 Apr; 317(1):387-94. PubMed ID: 16352699
[TBL] [Abstract][Full Text] [Related]
5. Discrimination of the amphetamine cue. Effects of A, B and mixed type inhibitors of monoamine oxidase.
Porsolt RD; Pawelec C; Roux S; Jalfre M
Neuropharmacology; 1984 May; 23(5):569-73. PubMed ID: 6429563
[TBL] [Abstract][Full Text] [Related]
6. Relative activity of some inhibitors of mono-amine oxidase in potentiating the action of tryptamine in vitro and in vivo.
MAXWELL DR; GRAY WR; TAYLOR EM
Br J Pharmacol Chemother; 1961 Dec; 17(3):310-20. PubMed ID: 14471627
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase inhibitors: nature of their interaction with rabbit pancreatic islets to alter insluin secretion.
Feldman JM; Chapman B
Diabetologia; 1975 Dec; 11(6):487-94. PubMed ID: 1107123
[TBL] [Abstract][Full Text] [Related]
8. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
Cabanillas AM; Masini-Repiso AM; Costamagna ME; Pellizas C; Coleoni AH
J Endocrinol; 1994 Nov; 143(2):303-8. PubMed ID: 7829993
[TBL] [Abstract][Full Text] [Related]
9. Discriminative properties of the psychostimulant dl-cathinone in a two lever operant task. Lack of evidence for dopaminergic mediation.
Goudie AJ; Atkinson J; West CR
Neuropharmacology; 1986 Jan; 25(1):85-94. PubMed ID: 2869439
[TBL] [Abstract][Full Text] [Related]
10. Anorexic properties of three monoamine oxidase inhibitors.
Willis GL; Smith GC
Pharmacol Biochem Behav; 1982 Dec; 17(6):1135-9. PubMed ID: 7163347
[TBL] [Abstract][Full Text] [Related]
11. Tryptamine: potentiation of its hyperthermic effect in rabbits by various monoamine oxidase inhibitors.
Quock RM
Pharmacol Res Commun; 1981 Mar; 13(3):281-6. PubMed ID: 6111091
[No Abstract] [Full Text] [Related]
12. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors.
Fagervall I; Ross SB
Biochem Pharmacol; 1986 Apr; 35(8):1381-7. PubMed ID: 2870717
[TBL] [Abstract][Full Text] [Related]
14. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
Karoum F
Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
[TBL] [Abstract][Full Text] [Related]
15. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
Lamensdorf I; Youdim MB; Finberg JP
J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal changes in striatal dopamine and beta-phenylethylamine induced by reserpine in the presence of monoamine oxidase inhibitors.
Juorio AV; Greenshaw AJ; Wishart TB
Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):644-8. PubMed ID: 3149722
[TBL] [Abstract][Full Text] [Related]
17. Lesion-induced reductions in trace amine accumulation: dependence on MAO inhibitor pretreatment.
Nguyen TV; Juorio AV; Greenshaw AJ
Brain Res Bull; 1989 Feb; 22(2):197-200. PubMed ID: 2495844
[TBL] [Abstract][Full Text] [Related]
18. The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum.
Philips SR; Boulton AA
J Neurochem; 1979 Jul; 33(1):159-67. PubMed ID: 572413
[No Abstract] [Full Text] [Related]
19. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
Severina IS
Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
[TBL] [Abstract][Full Text] [Related]
20. The effect of different substrates on the inhibition of rat brain and liver monoamine oxidase by arylalkylhydrazines.
Popov N; Matthies H; Lietz W; Thiemann C; Jassmann E
Biochem Pharmacol; 1970 Aug; 19(8):2413-8. PubMed ID: 5520601
[No Abstract] [Full Text] [Related]
[Next] [New Search]
